Fenchem officially announces the completion of doubling the supply of CellMotiveTM Coenzyme Q10. In 2015, Fenchem will try its best to meet the continuously increasing market with enlarged supply and local stocks around the world.
Fenchem CellMotive Coenzyme Q10 is derived from fermentation, which can meet the USP35 requirements to be applied in supplement and pharmaceutical industry. Coenzyme Q10 is a vitamin-like substance present in every cell of the body and serves as a coenzyme for several of the key enzymatic steps in the production of energy within the cell, and it also functions as an antioxidant with potential use as adjuvant therapy in heart disease and protects neurons against age-related degeneration.
Now there are seven Fenchem branches around the world, and these branches have normal stock for CellMotive Coenzyme Q10, especially for the U.S. office and two offices in Europe—Fenchem Germany and Fenchem Czech Republic—to guarantee the fast delivery service to the local customers.